SearchDictionaryMobileLogin

Jean-Pierre Després Selected Research

Obesity

05/2008Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men.
04/2008Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial.
02/2008Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program.
09/2007Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery.
03/2005Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men.
01/2004Molecular screening of the microsomal triglyceride transfer protein: association between polymorphisms and both abdominal obesity and plasma apolipoprotein B concentration.
01/2003Effect of the factor VII R353Q missense mutation on plasma apolipoprotein B levels: impact of visceral obesity.
01/2003The interleukin 6-174G/C polymorphism is associated with indices of obesity in men.
01/2003Visceral obesity attenuates the effect of the hepatic lipase -514C>T polymorphism on plasma HDL-cholesterol levels in French-Canadian men.
07/2002Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease.
05/20025' flanking variants of resistin are associated with obesity.

Articles by Research Topic

Disease

11Obesity
05/2008 - 05/2002
6Syndrome
09/2007 - 04/2003
5Coronary Artery Disease (Coronary Atherosclerosis)
04/2008 - 07/2002
3Overweight
02/2008 - 11/2005
3Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2008 - 06/2004
3Coronary Disease (Coronary Heart Disease)
11/2007 - 03/2003
3Myocardial Ischemia (Ischemic Heart Diseases)
03/2005 - 08/2002
2Dyslipidemias (Dyslipidemia)
11/2005 - 04/2003
1Atherosclerosis (Atheroma)
04/2008
1Weight Loss (Weight Reduction)
02/2008
1Weight Gain
02/2008
1Aortic Valve Stenosis (Aortic Stenosis)
01/2008
1Inflammation
01/2008
1Atrial Fibrillation
09/2007
1Hyperlipidemias (Hyperlipidemia)
12/2003
1Hypertriglyceridemia
07/2002

Drug/Important Bio-Agent (IBA)

5Glucose (Dextrose)FDA LinkGeneric
05/2008 - 07/2002
5rimonabantIBA
04/2008 - 11/2005
3ApolipoproteinsIBA
04/2006 - 01/2003
3Lipoproteins (Lipoprotein)IBA
03/2005 - 01/2004
2Interleukin-6 (Interleukin 6)IBA
05/2008 - 01/2003
2HDL CholesterolIBA
01/2004 - 01/2003
2C-Reactive ProteinIBA
04/2003 - 03/2003
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2008
1Insulin (Novolin)FDA Link
05/2008
1Carbon MonoxideIBA
02/2008
1AdiponectinIBA
01/2008
1oxidized low density lipoproteinIBA
01/2008
1Triad resinIBA
01/2008
1CholesterolIBA
11/2007
1LDL CholesterolIBA
04/2006
1LDL Receptors (LDL Receptor)IBA
01/2006
111-beta-Hydroxysteroid Dehydrogenase Type 1IBA
10/2004
1Cholesterol Ester Transfer ProteinsIBA
06/2004
1microsomal triglyceride transfer proteinIBA
01/2004
1Sex Hormone-Binding GlobulinIBA
06/2003
1Gemfibrozil (Lopid)FDA LinkGeneric
04/2003
1LDL Lipoproteins (beta Lipoproteins)IBA
03/2003
1Lipase (Acid Lipase)IBA
01/2003
1Factor VII (Proconvertin)IBA
01/2003
1Lipoprotein(a)IBA
08/2002
1ResistinIBA
05/2002

Therapy/Procedure

2Transplants (Transplant)
09/2007 - 07/2005
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
09/2007 - 08/2007